ACN vs ALKS · P/E 24, rev $17.60B vs P/E 14, rev $1.56B
Accenture plc (ACN) versus Alkermes Plc (ALKS) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Not investment advice. Open the ACN and ALKS stock pages for the full models.
Not investment advice.